HPS Pharmacies wish to give notice that Hospira Pty Ltd are currently experiencing an interruption to the supply of:
Hospira™ Cefoxitin 1g Vials
This supply interruption is due to a manufacturing issue with the active pharmaceutical ingredient. Normal supplies are expected to resume in December 2016. While wholesaler stocks are exhausted, HPS Pharmacies are still able to source a limited supply for the benefit of our clients.
Cefoxitin is a moderate-spectrum cephalosporin with significant anti-anaerobic activity. Metronidazole demonstrates superior anti-anaerobic activity and may be combined with an alternative cephalosporin, such as cefazolin, for additional gram-positive cover.
In concordance with antimicrobial stewardship recommendations, prescribers are advised to consult the Therapeutic Guidelines: Antibiotic for an appropriate alternative.
Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact your pharmacist at HPS Pharmacies, or Hospira Australia on 1300 046 774.
Information regarding expected dates for supply may vary subject to delays which are out of our control. HPS Pharmacies does not accept responsibility for such changes but will endeavour to keep our clients updated as information is made available from drug manufacturers or wholesalers.